Laryngeal dystonia secondary to neuroleptic medications.
Vogler
C M
CM
Szonyli
G
G
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001590:Benztropine / Q000627:therapeutic use; D018492:Dopamine Antagonists / Q000008:administration & dosage / Q000009:adverse effects*; D004421:Dystonia / Q000139:chemically induced* / Q000188:drug therapy; D005260:Female; D005500:Follow-Up Studies; D006220:Haloperidol / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007818:Laryngeal Diseases / Q000139:chemically induced* / Q000188:drug therapy; D018570:Risk Assessment; D014268:Trifluoperazine / Q000009:adverse effects* / Q000627:therapeutic use
D018492:Dopamine Antagonists; D001590:Benztropine; D014268:Trifluoperazine; D006220:Haloperidol